Related references
Note: Only part of the references are listed.Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model
Francois Briand et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation
Lili Sheng et al.
JOURNAL OF PATHOLOGY (2017)
Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats
Qian Zhang et al.
PLOS ONE (2017)
Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota?
Audrey M. Neyrinck et al.
NUTRIENTS (2017)
Resistant starch can improve insulin sensitivity independently of the gut microbiota
Laure B. Bindels et al.
MICROBIOME (2017)
Fat binding capacity and modulation of the gut microbiota both determine the effect of wheat bran fractions on adiposity
Francesco Suriano et al.
SCIENTIFIC REPORTS (2017)
A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism
Estelle Grasset et al.
CELL METABOLISM (2017)
Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis
Erin E. Mulvihill et al.
CELL METABOLISM (2017)
Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia
Laure B. Bindels et al.
ISME JOURNAL (2016)
CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology
Anneleen Mortier et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Bifidobacteria possess inhibitory activity against dipeptidyl peptidase-IV
Z. Zeng et al.
LETTERS IN APPLIED MICROBIOLOGY (2016)
High fat diet impairs the function of glucagon-like peptide-1 producing L-cells
Paul Richards et al.
PEPTIDES (2016)
Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women
Nuria Salazar et al.
CLINICAL NUTRITION (2015)
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
A. Psichas et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice
Angela Moya-Perez et al.
PLOS ONE (2015)
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
Nina Wronkowitz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV(DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective
R. N. Kushwaha et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Erin E. Mulvihill et al.
ENDOCRINE REVIEWS (2014)
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
Na-Ri Shin et al.
GUT (2014)
Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity
Amandine Everard et al.
ISME JOURNAL (2014)
Phylogenetic distribution of three pathways for propionate production within the human gut microbiota
Nicole Reichardt et al.
ISME JOURNAL (2014)
Obese patients have higher circulating protein levels of dipeptidyl peptidase IV
Andreas Stengel et al.
PEPTIDES (2014)
Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
Henrike Sell et al.
DIABETES CARE (2013)
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna et al.
ENDOCRINOLOGY (2013)
CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
Sang Ah Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Characterization of the Recombinant Exopeptidases PepX and PepN from Lactobacillus helveticus ATCC 12046 Important for Food Protein Hydrolysis
Timo Stressler et al.
PLOS ONE (2013)
Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
Yan-Ling He
CLINICAL PHARMACOKINETICS (2012)
Innate immunity in the small intestine
Rebeca Santaolalla et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Disruption of the Murine Glp2r Impairs Paneth Cell Function and Increases Susceptibility to Small Bowel Enteritis
Seung-Jun Lee et al.
ENDOCRINOLOGY (2012)
Sitagliptin Exerts an Antinflammatory Action
Antoine Makdissi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Gut Barrier New Acquisitions and Therapeutic Approaches
Franco Scaldaferri et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice
Yan Y. Lam et al.
PLOS ONE (2012)
Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
Aurelie Waget et al.
ENDOCRINOLOGY (2011)
Targeting gut microbiota in obesity: effects of prebiotics and probiotics
Nathalie M. Delzenne et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue
Lucie Geurts et al.
FRONTIERS IN MICROBIOLOGY (2011)
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
Nga N. Ta et al.
ATHEROSCLEROSIS (2010)
Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
A. J. Scheen
DIABETES OBESITY & METABOLISM (2010)
GIP and GLP-1, the two incretin hormones: Similarities and differences
Yutaka Seino et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
P. D. Cani et al.
GUT (2009)
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface
Shipra Vaishnava et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock
AM Neyrinck et al.
JOURNAL OF NUTRITION (2004)
Cloning and functional expression of dipeptidyl peptidase IV from the ruminal bacterium Prevotella albensis M384
ND Walker et al.
MICROBIOLOGY-SGM (2003)
Purification and characterization of an X-prolyl-dipeptidyl peptidase from Lactobacillus sakei
Y Sanz et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Share Paper
